Status:
COMPLETED
Labor and Delivery Doula Program to Reduce Perinatal Morbidity and Mortality in Kansas
Lead Sponsor:
University of Kansas Medical Center
Collaborating Sponsors:
BioNexus KC
Blue KC (Blue Cross Blue Shield)
Conditions:
Pregnancy Related
Doula Care
Eligibility:
FEMALE
16-50 years
Phase:
NA
Brief Summary
The study was done to learn how doula-enhanced care provided to Black birthing people improved perceived communication and quality care.
Eligibility Criteria
Inclusion
- Black birthing people
- Received care and plan to delivery at the University of Kansas Medical Center
- Scored positive to social determinants of health screener
- Gestational age between 14-27.6 weeks at enrollment
Exclusion
- Pregnancy not viable or pregnancy not intrauterine on ultrasound
- Patients who are not willing to be randomized into not receiving doula enhanced
- Patients who do not plan to delivery at the University of Kansas Health System
- Non-Black birthing people.
- Planned cesarean section
- Patients with a known major fetal anomaly
- Non-English speaking
Key Trial Info
Start Date :
May 12 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07157059
Start Date
May 12 2023
End Date
November 1 2024
Last Update
September 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Kansas Medical Center
Kansas City, Kansas, United States, 66160